In Vitro Antimicrobial Activity of Taurolidine Against Isolates Associated with Catheter-Related Bloodstream Infections
Jared L. Crandon, Xing Tan, Paul R. Rhomberg, Mariana Castanheira, S. J. Ryan Arends · 2026
Read In Vitro Antimicrobial Activity of Taurolidine Against Isolates Associated with Catheter-Related Bloodstream Infections by Jared L. Crandon, Xing Tan, Paul R. Rhomberg, Mariana Castanheira, S. J. Ryan Arends (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13509582.txt.
Description
Jared Crandon and four co-authors test a catheter lock drug against germs that cause bloodstream infections, in a 2026 study. Patients on dialysis through central lines face frequent catheter infections. Taurolidine, a broad antimicrobial used in lock solutions, is approved to reduce those infections when paired with heparin.
The team challenged 442 bacterial and 50 yeast isolates from bloodstream infections, including drug-resistant strains, using standard laboratory methods. The drug was highly active against nearly everything, with typical stopping concentrations at or below 1,024 micrograms per milliliter. A few hardy organisms needed more, but every isolate was stopped at the strength of the commercial product. Resistance to other drugs did not weaken its effect. The authors say the lab results support the idea that such locks can guard against a wide range of pathogens.
Catalog record
| CREATOR | Jared L. Crandon, Xing Tan, Paul R. Rhomberg, Mariana Castanheira, S. J. Ryan Arends |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 16 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |